Mono-POC Ethyl Tenofovir
| Product Name | Mono-POC Ethyl Tenofovir |
|---|---|
| Alternate Names | Tenofovir Impurities, Impurities of Tenofovir |
| CAT No. | CS-O-11174 |
| CAS No. | 1796539-92-8 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 431.38 g/mol |
| Mol. For. | C16H26N5O7P |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tenofovir |
| Purity | Not less than 90 % |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | C[C@@H](OC[P](OCOC(OC(C)C)=O)(OCC)=O)CN1C2=NC=NC(N)=C2N=C1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Mono-POC Ethyl Tenofovir is a novel prodrug of Tenofovir, which is used in the treatment of HIV and Hepatitis B virus infections. It is a nucleotide analog reverse transcriptase inhibitor that works by blocking the replication of the virus. Mono-POC Ethyl Tenofovir is designed to improve the bioavailability and pharmacokinetics of Tenofovir, thereby reducing the frequency of dosing and minimizing adverse effects.
The chemical structure of Mono-POC Ethyl Tenofovir consists of a phosphonamidate prodrug linked to a lipophilic ethyl group. The lipophilic nature of this compound allows for increased cellular uptake and better distribution into the target cells. The prodrug is selectively activated by esterases in the plasma and liver, releasing the active form of Tenofovir.
Mono-POC Ethyl Tenofovir is administered orally and has been studied in clinical trials for its safety and efficacy. It has shown promising results in reducing viral load and improving immune function in HIV-infected patients. Additionally, it has been found to be effective in the treatment of chronic Hepatitis B infections.
In conclusion, Mono-POC Ethyl Tenofovir is a prodrug of Tenofovir that has been designed to improve its bioavailability and pharmacokinetics. It has shown promising results in the treatment of HIV and Hepatitis B virus infections and may offer a safer and more effective alternative to current therapies.
Get an Instant Quote
Related Compounds
Tenofovir disoproxil impurity L | Tenofovir disoproxil impurity L fumarate | Tenofovir DP-IV | Tenofovir alafenamide (RRS) diasteroisomer | Tenofovir Impurity 98 | Tenofovir Monomethyl Ester | Mono poc-isopropyl-Tenofovir fumarate salt | nPOC-POC Tenofovir Fumarate | tenofovir related impurity | Tenofovir EP Impurity C Succinate | Tenofovir Disoproxil T8 Impurity | Mono-POC Tenofovir 6-Isopropyl Carbamate | Tenofovir alafenamide lactose Millard Reaction product-3 | Tenofovir Related Compound 5 | Tenofovir DP-V | Diisopropyl Tenofovir Fumarate | Tenofovir Alafenamide Glycosamine product | TAF SRS diastereomer | Tenofovir Impurity 36 (RSR) 2,3-dihydroxysuccinate salt | Tenofovir isomer 6&1 | Tenofovir Disoproxil Fumarate Impurity | Tenofovir Disoproxil Fumarate USP RC J | Tenofovir Alafenamide Enantiomer | Tenofovir Bis ((R)-9-(2-Hydroxypropyl)adenine) dimer Acetate salt | Tenofovir Alafenamide Racemic D Isomer | TAF methyl ester | Mono-POC Methyl Tenofovir Fumarate (Mixture of Diastereomers) | Tenofovir Impurity 39 (RRR) 2,3-dihydroxysuccinate salt | Tenofovir Impurity 35 | Tenofovir diphosphate | Tenofovir Mono-POC methyl ester | Tri-POC Tenofovir Dimer | Tenofovir Disoproxil T5 Impurity | Tenofovir alafenamide Methyl ester impurity | Tenofovir Alanine ester impurity | MOC-POC Tenofovir | TAF Propyl ester Impurity | Tenofovir Impurity 59 | Tenofovir Alfenamide Amadori Rearrangement product | Tenofovir Alafenamide (RSR) Diasteroisomer | Tenofovir Disoproxil Dimer | Tenofovir Mono POC Dimer Diethyl amine salt | nPOC-POC Tenofovir | Tenofovir Disoproxil T12 Impurity | Tenofovir alafenamide Impurity 5 | Isopropyl Tenofovir | Ethyl Tenofovir Impurity | Tenofovir Alafenamide fumarate | Diethylaminocarboxymethyl POC Tenofovir Fumarate | Tenofovir Disoproxil T11 Impurity | Tenofovir alafenamide Impurity 2 | Tenofovir Impurity 62 | Tenofovir Alafenamide Dimer Impurity II | Tenofovir disoproxil phosphate | Diethylaminocarboxymethyl POC Tenofovir (Mixture of Diastereomers) | Mono-POC Isopropyl Tenofovir | Tenofovir alafenamide impurity | Tenofovir Mixed dimer | Tenofovir alafenamide Impurity 3 | Mono ester impurity (Tenofovir) | Tenofovir Diphenyl HemiFumarate salt | Tenofovir Disoproxil T7 Impurity | Tenofovir Disoproxil (S)-Isomer fumarate salt | Tenofovir Related Compound 14 | Desmethyl Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Isopropoxycarbonyl | Tenofovir Impurity 89 | Tenofovir Isopropyl Carbamate | Tenofovir Impurity 59-D6 | Tenofovir alafenamide lactose Millard Reaction product-2 |